European shares hit 1-year high on M&A deal, Actelion soars

LONDON, Jan 26 (Reuters) - European shares climbed to a

one-year high on Thursday after news that Johnson & Johnson

will buy the Swiss biotech firm Actelion in a

$30 billion deal.

Read more